We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “If the patients were doing fine at 30 days, meaning ...
(UPDATED) MASTER DAPT, the latest and largest randomized clinical trial to tackle the conundrum of dual antiplatelet therapy (DAPT) duration in post-PCI patients at high risk for bleeding, indicates ...
PARIS, France—One month of dual antiplatelet therapy (DAPT) after PCI using contemporary stents not only is associated with similar rates of adverse clinical outcomes compared with 3 months or more in ...
Another trial has added to the movement towards shortening the duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). In the MASTER DAPT trial involving patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback